Recent advances in immune checkpoint therapy in non-small cell lung cancer and opportunities for nanoparticle-based therapy
Mohammad‐Javad Sanaei, Atieh Pourbagheri‐Sigaroodi, Vahid Kaveh, Hassan Abolghasemi, Seyed H. Ghaffari, Majid Momeny, Davood Bashash
Topics & Concepts
DurvalumabIpilimumabNivolumabAtezolizumabPembrolizumabImmune checkpointMedicineAvelumabTremelimumabImmune systemImmunotherapyLung cancerOncologyCancer researchImmunologyCancer Immunotherapy and BiomarkersLung Cancer Research StudiesImmune cells in cancer